Englander Israel A 的 Form 4 申報

Faeth Therapeutics, Inc.（FTH），2026/5/15 申報

申報編號: 0001104659-26-062608
申報時間: 2026/5/15 16:24 ET
交易日: 2026/4/2-4/7
申報延遲: 43 天遲報
10b5-1 計畫: 沒有勾選

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 17 筆非衍生性交易。公開市場買進合計 $14.1 萬。公開市場賣出合計 $53.8 萬。交易後 43 天才申報，超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Englander Israel ACIK 0001017456	持股 10% 以上大股東
Millennium Management LLCCIK 0001273087	持股 10% 以上大股東
Millennium Group Management LLCCIK 0001446830	持股 10% 以上大股東
Ics Opportunities II LLCCIK 0001783647	持股 10% 以上大股東

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式
2026/4/2	Common Stock	P買進取得	+26	$33.47^F1	+$870.23	144,974	間接
2026/4/2	Common Stock	P買進取得	+1,276	$34.75^F4	+$44,344.06	144,974	間接
2026/4/2	Common Stock	P買進取得	+701	$35.55^F5	+$24,918.59	144,974	間接
2026/4/2	Common Stock	S賣出處分	−3,099	$30.86^F6	−$95,646.92	144,974	間接
2026/4/2	Common Stock	S賣出處分	−1,265	$31.75^F7	−$40,165.02	144,974	間接
2026/4/2	Common Stock	S賣出處分	−1,794	$32.60^F8	−$58,491.76	144,974	間接
2026/4/2	Common Stock	S賣出處分	−374	$33.35^F9	−$12,471.78	144,974	間接
2026/4/2	Common Stock	S賣出處分	−1,134	$34.80^F10	−$39,463.99	144,974	間接
2026/4/6	Common Stock	P買進取得	+1,104	$31.02^F11	+$34,246.08	141,029	間接
2026/4/6	Common Stock	S賣出處分	−1,214	$31.02^F12	−$37,661.56	141,029	間接
2026/4/6	Common Stock	S賣出處分	−45	$31.96^F13	−$1,438.33	141,029	間接
2026/4/7	Common Stock	P買進取得	+1,108	$33.38^F14	+$36,985.04	133,986	間接
2026/4/7	Common Stock	S賣出處分	−2,115	$28.94^F15	−$61,211.7	133,986	間接
2026/4/7	Common Stock	S賣出處分	−205	$29.71^F16	−$6,091.49	133,986	間接
2026/4/7	Common Stock	S賣出處分	−4,423	$31.38^F17	−$138,812.76	133,986	間接
2026/4/7	Common Stock	S賣出處分	−300	$32.25^F18	−$9,674.01	133,986	間接
2026/4/7	Common Stock	S賣出處分	−1,108	$33.38^F19	−$36,985.04	133,986	間接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

Represents volume-weighted average price ("VWAP") of purchases of 26 shares of common stock ("Common Stock"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the "Company") on April 2, 2026 at prices ranging from $32.90 to $33.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein.

表 I 有 1 筆交易的價格引用這則附註。

Represents VWAP of purchases of 1,276 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.97 to $34.90.

表 I 有 1 筆交易的價格引用這則附註。

Represents VWAP of purchases of 701 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $35.4481 to $35.91.

表 I 有 1 筆交易的價格引用這則附註。

Represents VWAP of sales of 3,099 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $30.1332 to $31.1212.

表 I 有 1 筆交易的價格引用這則附註。

Represents VWAP of sales of 1,265 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $31.21 to $32.15.

表 I 有 1 筆交易的價格引用這則附註。

Represents VWAP of sales of 1,794 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $32.22 to $33.1251.

表 I 有 1 筆交易的價格引用這則附註。

Represents VWAP of sales of 374 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.23 to $33.45.

表 I 有 1 筆交易的價格引用這則附註。

F10

Represents VWAP of sales of 1,134 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $34.40 to $35.25.

表 I 有 1 筆交易的價格引用這則附註。

F11

Represents purchases of 1,104 shares of the Company's Common Stock on April 6, 2026 at $31.02 per share.

表 I 有 1 筆交易的價格引用這則附註。

F12

Represents VWAP of sales of 1,214 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $30.64 to $31.345.

表 I 有 1 筆交易的價格引用這則附註。

F13

Represents VWAP of sales of 45 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $31.80 to $32.17.

表 I 有 1 筆交易的價格引用這則附註。

F14

Represents VWAP of purchases of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share.

表 I 有 1 筆交易的價格引用這則附註。

F15

Represents VWAP of sales of 2,115 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $28.5071 to $29.3167.

表 I 有 1 筆交易的價格引用這則附註。

F16

Represents VWAP of sales of 205 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $29.695 to $30.50.

表 I 有 1 筆交易的價格引用這則附註。

F17

Represents VWAP of sales of 4,423 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $30.9852 to $31.813.

表 I 有 1 筆交易的價格引用這則附註。

F18

Represents VWAP of sales of 300 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $32.0625 to $32.615.

表 I 有 1 筆交易的價格引用這則附註。

F19

Represents sales of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share.

表 I 有 1 筆交易的價格引用這則附註。

備註

Assuming, without conceding, the application of Section 16(b) of the Securities Exchange Act of 1934, the reporting persons have disgorged to the Company all amounts that could be deemed profit realized by them from the transactions in the Company's Common Stock reported on this Form 4 and the other two statements on Form 4 filed by Millennium Management LLC on the same date.

看 SEC EDGAR 上的完整原文（在新分頁開啟）